Yaşlı hastada senkopa yaklaşım

AKÇİÇEK, Fehmi; ŞAHİN, SEVNAZ

Yaşlı hastada senkopa yaklaşım

Sevnaz ŞAHİN, (Ege Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, İzmir, Türkiye)

Fehmi AKÇİÇEK (Ege Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, İzmir, Türkiye)

Türk Geriatri Dergisi

2 1

Yıl: 2010 Cilt: 13 Sayı: 3 Sayfa Aralığı: 208 - 218 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Yaşlı hastada senkopa yaklaşım

Öz:

Yaşlı hastada senkop, gerek acil servislerde gerekse polikliniklerde sık karşılaşılan ve etiyolojiye bağlı olarak mortaliteye neden olabilen klinik bir sendromdur. Temel patoloji, serebral global hipoperfüzyondur. Her yaş grubunda görülmekle birlikte artan yaşla birlikte senkop sıklığında da artış meydana gelir. Yaşa bağlı meydana gelen değişiklikler yaşlıda senkop gelişimine katkıda bulunmaktadır. Senkopun prognozunu altta yatan hastalık belirlemektedir. Yaşlı hastada senkop nedenleri çok çeşitli olabilmekle bununla birlikte mortalitedeki artış kardiyak senkoplarda görülmektedir. Bu nedenle de senkopta etiyolojinin saptanması son derece önemlidir. Senkopla başvuran her hastada ayrıntılı öz geçmiş, fizik muayene ve EKG ile tanıya ulaşılamazsa gerekli diğer noninvasiv veya invasiv tetkiklere geçilmelidir.Nöral yolaklarla ilişkili senkopta nonfarmakolojik yaklaşım ön plandadır. Öz geçmişte hastanın kullandığı ilaçlar değerlendirilmeli, hipotansiyondan sorumlu ilaç varlığında kesilmeli veya dozu azaltılmalıdır. Hastalar senkopu tetikleyecek nedenler hakkında bilgilendirilmelidir. Kardiyak senkopta saptanan kardiyak patolojinin bağlı spesifik tedavi uygulanmalıdır ve uygun vakalarda intrakardiyak defibrilatör (ICD) hayat kurtarıcıdır. Yaşlıda senkop, kapsamlı değerlendirme, hızlı tanı ve tedavi gerektiren önemli bir geriatrik sendromdur.

Anahtar Kelime:

Konular: Geriatri ve Gerontoloji

Management of syncope in the elderly

Öz:

Syncope in elderly patients is a clinical syndrome frequently observed both in emergency rooms and outpatient clinics and it may cause mortality depending on the etiology. The main pathology at the background is global cerebral hypoperfusion. Although syncope may be seen at all age groups, it is more common in older ages. Age-associated changes in various physiological parameters contribute to development of syncope in the elderly and the underlying etiology determines its prognosis.Among the many types of syncope in the elderly, cardiac syncope is the primary syndrome resulting in increased mortality. Therefore, identification of the etiology is very important in the management of syncope. When detailed anamnesis, physical examination and EKG are inadequate for the diagnosis of an elderly syncope patient, further invasive or noninvasive examination should be performed.In the case of syncope related to neural pathways, nonpharmacological approaches are preferred. Physicians should evaluate all the medications the patient is using and the withdrawal or reduction of culprit medication should be considered. Patients must be informed about the reasons and triggers of syncope. Patients with cardiac syncope require specific treatment and an implantable cardiac defibrillator (ICD) may be life saving for appropriate indications. Syncope in the elderly is an important geriatric syndrome that requires comprehensive assessment, rapid diagnosis and treatment.

Anahtar Kelime:

Konular: Geriatri ve Gerontoloji

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Jhanjee R, Dijk Vg, Sakaguchi S et al. Syncope in adults: terminology, classification, and diagnostic strategy. Pacing Clin Electrophysiol 2006;29(2): 1160-9.
2. Thijs RD, Benditt DG, Mathias CJ Et Al. Unconscious confusion- a literature search for definations of syncope and related disorders. Clin Auton Res. 2005;15(1):35-9.
3. Litsitz LA,Wei Jy, Rowe JW. Syncope in an elderly, institutionalized, population: prevalence, incidence, and associated risk. Q J Med 1985; 216:45-55.
4. Soteriades ES, Evans JC, Larson MG et al. Incidence and prognosis of syncope N. Engl. J Med 2002; 347: 878-85.
5. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine 1990;69:160-75
6. Brignole M, Menozzi C, Bartoletti A. Et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006; 27:76-82.
7. Day SC, Cook EF, Funkenstein H, Goldman l. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am. J Med 1982; 73:15-23.
8. Disertori M, Brignole M, Menozzi C, et al. Management of patients with syncope referred urgently to general hospitals. Europace 2003; 5: 283-91.
9. Parry SW, Newton JL, Fearson R et al. Evidence based algorithms and the management of falls and syncope ın the acute medical setting. Clin Med 2008; 8:157-62.
10. Amer Alshekhee MD, Msc, Win-Kuang Shen, MD, Judith Macall, MD et al. Incidence and mortality rate of syncope in the united states. The American Journal of Medicine 2009;122(2): 181-8.
11. Getchell WS, Larsen GC, Morris CD et al. Epidemiology of syncope in hospitalized patients. J Gen Intern Med 1999;14: 677-87.
12. Hoefnagels WA, Padberg GW, Overweg J et al. Transient loss of consciousness: the value of the history for distinguishing seizure from syncope. J Neurol 1991;238: 39-43.
13. Lempert T, Bauer M, Schmith D Syncope: a video metric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 1994;36:233-7.
14. Hazard Rw, Blass J, Halter Jeffery BH (ed). Principle of Geriatric Medicine And Gerontology The Mcgraw-Hill Company, USA, 2003.
15. Shimada K, Kitazumi T, Ogura H, et al. Effects of age and blood pressure on the cardiovascular responses to the valsalva meneuver. J Am Geriat Soc 1986;34:431-4.
16. The Merck Manual of Geriatrics 3 Rd Edition Update Online’ Section 11, Chapter 83: Aging And Cardiovasculer System, http://www.merck.com/mkgr/mmg/sec11/ch83/ch83c.jsp, July 9, 2009.
17. Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope. Europace 2004; 6:467-537.
18. Kapoor WN, Smith MA, Miller NL. Upright tilt testing testing in evaluating syncope : a comprehensive literature review. Am J Med 1994;97:78-88.
19. Benditt G, Remole S, Bailin S et al. Tilt table testing for evaluation of neurorally-mediated (cardioneurogenic) syncope: rationale and proposed protocols. Pacing Clin Electrophysiol 1991;14:1528-37.
20. Tan PM, Parry WS. Vasovagal syncope in the older patient. JACC 2008;51(6): 599-606.
21. Lewis T. Vasovagal syncope and carotid sinus mechanism. Br Med J 1932;873-6.
22. Accurso V, Winnicki M, Shamsuzzaman AS et al. Predisposition to vasovagal syncope ın subject with blood/injury phobia Circulation 2001;104: 903-7.
23. Van Lieshout JJ, Wieling W, Karemaker JM Et Al. The vasovagal response. Clin Sci Lond 1991; 81: 575-86.
24. Nynke Van Dijk, Mardi C. Boer, Tiziana De Santo et al. Daily, weekly, monthly, and seasonal patterns in the occurrence of vasovagal syncope in an older population Europace 2007;9(9):823-8.
25. Ruiz GA, Madoery C, Arnaldo F et al. Frequency-domain analysis of heart rate variability during positive and negative head-up tilt test: importance of age. Pacing Clin Electrophysiol 2000;23:325-32.
26. Brignole M, Menozzi C, Del Rosso A et al. New classification of hemodynamic of vasovagal syncope: beyond the vasıs classification. Europace 2000;2:66-76.
27. Kochiadakis GE, Papadimitriou EA, Maketou ME et al. Autonomic nervous system changes in vosagal syncope: is there any difference between young and older patiens? Pacing Clin Electrophysiol 2004;27:1371-7.
28. Benditt Dg, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. JACC 1996,28:263.
29. Sutton R, Peterson M, Brignole M et al. Proposed classification for tilt induced vasovagal syncope. Eur J Card Pacing Electrophysiol 1992;2:180-3.
30. Ungar A, Mussi C, Del Rosso A et al. Diagnosis and characteristics of syncope in older patients referred to geriatric departments JAGS 2006; 54: 1531-6.
31. Jansen, RW, Lipsitz, LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995; 122:286-95.
32. Walter PF, Crawley IS, Dorney WR. Carotid sinus hypersensitivity and syncope. Am J Cardiol 1978;42:396-403.
33. Richardson DA, Bexton RS, Shaw FE, Kenny RA. Prevalence of cardio inhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the accident and emergency department with ‘unexplained’ or recurrent falls. Pacing Clin Electrophsiol 1997;20:820-3.
34. Rose Anne M Kenny, David A Richardson, Nick Steen et al. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE) JACC 2001;38:5: 1491-16.
35. Brignole M, Gigli G, Altomonte F, et al. The cardio inhibitory reflex evoked by carotid sinus stimulation in normal and in patients with cardiovascular disorders. Ital Cardiol 1985;15:514-9.
36. Brignole M, Menozzi C, Gianfranchi L, et al. Carotid sinus massage, eyeball compression and head up tilt test in patients with syncope of uncertain origin and in healthy control subject. Am Heart J 1991;122:1644-51.
37. Volkmann H, Schnerch B, Kuhnert H. Dianostic value of carotid sinus hypersensitivity. Pacin Clin Electrophysiol 1990;13:2065-70.
38. Mcintoch SJ, Da Costa D Kenny RA. Outcome of an integrated approach to the ınvestigation of dizziness, falls and syncope in elderly patients referred to syncope clinic. Age Aging 1993;22:53-5.
39. Puggioni E, Guiducci V, Brignole M, Et Al. Results and complications of the carotid sinus massage performed according to the ‘methods of symptoms’. Am J Cardiol 2002;89:599-601.
40. The consensus committee of the American autonomic society the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension pure autonomic failure multiple systems atrophy. Neurology 1996; 46: 1470.
41. Luukinen H, Koski K, Laippla P, Kivela SL. Prognosis of diastolic and systolic ortostatic hypotension in older persons. Arch Intern Med 1999;159:273-80.
42. Deegan BMT, O’Connar M, Donnelly T Et Al. Orthostatic hypotension: a new classification system. Europace 2007;9:937-41.
43. Gupta V, Lipsitiz L. Orthostatic hypotension in the elderly: diagnosis and treatment.The Ame. Journ. Of Medicine 2007; 120, 841-7.
44. Metz TF. Drug-induced orthostatic hypotension in older patients. Drugs Aging 1995;6:219-28.
45. Reid JL, Macdonald NJ, Lees KR, et al. Angiotension-convertin enzyme inhibitors in the elderly. Am Heart J 1989;117:751-55.
46. Robertson DRC, George CF. Drug therapy for Parkinson’s disease in the elderly. Br Med Bull 1990;46:124-46.
47. Jansen RWMM, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995;122:286-95.
48. Manolis AS, Linzer M, Salem D, Estes NAM. Syncope: current diagnostic evaluation and management. Ann Intern Med 1990;112:850-63.
49. Galizia G, Abete P, Mussi C. Role of early symptoms in assessment of syncope in elderly people: results from the Italian group for the study of syncope in the elderly. J Am Geriatrics Soc 2009;57:18-23.
50. Olshansky B, Hahn A. Elizabeth, Hartz V et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. Am. Heart J 1999,137 (5):878-86.
51. Williams L, Frenneaux M. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Europace 2007:9;817-22.
52. Maron BJ. Hypertrophic cardiomyopathy : a systematic review. JAMA 2002;287:1308-20.
53. Calvo- Romero JM, Perez- Miranda M, Bureo- Dacal P. Syncope in acute pulmonary embolism. Eur J Emerg Med 2004;11:208-9.
54. Albers GW Caplan LR, Easton JD. Transient ischemic attackproposal for a new definition. New Eng J Med 2002;347:1713-6.
55. Meissner I, Wiebers DO, Swanson JW. The natural history of drop attacks. Neurology 1986;36:1029-34.
56. Theron, J, Melancon, D, Ethier, R. “Pre” subclavian steal syndromes and their treatment by angioplasty: hemodynamic classification of subclavian artery stenoses. Neuroradiology 1985; 27:265.
57. Huff JS, Decker WW, Quinn JV, et al. America college of emergency physicians clinical policies committee (writing committee) on syncope. Clinical policy critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Ann Emerg Med 2007;49(4):431-44.
58. Quinn JV, Stiell IG, Mcdermott DA, Et Al. Derivation of the San Francisco syncope rule to predict patients with short-term serious outcomes. Ann Emergency Medicine. 2004; 43: 224 32.
59. Strickberger SA, Woodrow Benson D, Biaggioni, et al. AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: In Collaboration With the Heart Rhythm Society: Endorsed by the American Autonomic Society. Circulation 2006; 113:316-27.
60. Kapoor WN, Fortunato M, Hanusa SH Et Al. Psychiatric illnesses in patients with syncope. Am J Med 1995;99:505-12.
61. Linzer M, Yang EH, Estes NA Et Al. Diagnosis syncope, Part 1: value of history, physical examination, and electrocardiography. Clinical efficacy assessment project for america college of physician. Ann Intern Med 1997; 126: 989-96.
62. Krahn AD, Klein GJ, Yee R Et Al. Use of an extended monitoring strategy in patients with problematic syncope. Reveal investigators. Circulation 1999;99:406-10.
63. Görenek B, Çavuşoğlu Y, Kubaiberdieva G Ve Ark. Çarpıntnedeni ile aritminin belirlenmesinde implante edilebilir loop recorder (ilk deneyim). T. Klin. Kardioloji 2001;14: 180-183.
64. Assar M, Krahn A, Klein G Et Al. Optimal duration of monitoring in patients with unexplaind syncope. Am J Cardio 2003; 92: 1231-3.
65. Brignole M, Croci F, Menozzi C, Et Al. Isometric arm counter pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002; 40:2053-9.
66. Van Dijk JG, Quartieri F, Blanc JJ, Et Al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope. (PC-Trial). J Am Coll Cardiol 2006; 48: 1652-7.
67. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled tri-al of acute and long term medical therapy in tilt induced neurally mediated syncope. Am. J. Cardiol 1992; 70: 339-42.
68. Di Giralamo E, Di Lorio C, Sabatini P, et al. Effects of paroxetine hydrochloride, e selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, plecebo-controlled study. J Am Coll Cardiol 1999; 33. 1227-30.
69. Lee TM, Su SF, Chen MF, et al. Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 1996;78:480-2.
70. Alegria JR, Gersh BJ, Scott CG, et al. Comparison of frequency of recurrent syncope after beta blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 2003;92:82-4.
71. Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of atenolol fort he prevention of neurally mediated syncope ın a highly symptomatic population:A prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37:554-9.
72. Sheldon R, Connolly S, Rose S, et al. Prevention of syncope trial (POST): A randomized, placebo-controlled study of metop-
rolol in the prevention of vasovagal syncope. Circulation 2006;113:1164-70.
73. Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence ın children. A doubleblind, placebo controlled, randomized trial. J Am Coll Cardiol 2005;45:484-8.
74. Samniah N, Sakaguchi S, Luria KG, et Al. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 2001;88:80-3.
75. El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and ortostatic tolerance in patients with unexplained syncope. Heart 1996;75:134-40.
76. Hussian RM, Mcıntosh SJ, Lawson J, Kenny RA. Fludrocortisone in the treartment of hypotensive disorders in the elderly. Heart 1996;76:507-9.
77. Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: A role in the management of neurocardiogenic syncope. Heart 1998;79:45-9.
78. Gaggioli G, Bottoni N, Mureddu R, Et Al. Effects of chronic vasodilator therapy to enhance to vasovagal syncope during upright tilt testing. Am J Cardiol 1997;80:1092-4.
79. The task force on syncope, European society of cardiology. Guidelines on management (diagnosis and treatment) of syncopeUpdate 2004. Europace 2004;6:467-537.
80. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the ACC/AHH/NASPE 2002 Guidlines Update For Implantation Of Cardiac Pacemakers And Antiarrhytmia Devices. Circulation 2008;117:E350-408.
81. Low Pa, Gilden Jl, Freeman R, et Al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine study group. JAMA 1997;277:1046-51.
82. Kochar Ms, Itskowictz Hd. Treatment of idiopathic hypotension (Shy-Drager Syndrome) with indomethacin. Lancet 1978;1:1011-4.
83. Hoeldtke Rd, Streetan Dhp. Treatment of orthostatic hypotension with erythropoietin. N Eng J Med 1993;329:611-5.
84. Onrot J, Goldberg MR, Biaggioni I et Al. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med 1985; 313:549-54.

APA	ŞAHİN S, AKÇİÇEK F (2010). Yaşlı hastada senkopa yaklaşım. , 208 - 218.
Chicago	ŞAHİN SEVNAZ,AKÇİÇEK Fehmi Yaşlı hastada senkopa yaklaşım. (2010): 208 - 218.
MLA	ŞAHİN SEVNAZ,AKÇİÇEK Fehmi Yaşlı hastada senkopa yaklaşım. , 2010, ss.208 - 218.
AMA	ŞAHİN S,AKÇİÇEK F Yaşlı hastada senkopa yaklaşım. . 2010; 208 - 218.
Vancouver	ŞAHİN S,AKÇİÇEK F Yaşlı hastada senkopa yaklaşım. . 2010; 208 - 218.
IEEE	ŞAHİN S,AKÇİÇEK F "Yaşlı hastada senkopa yaklaşım." , ss.208 - 218, 2010.
ISNAD	ŞAHİN, SEVNAZ - AKÇİÇEK, Fehmi. "Yaşlı hastada senkopa yaklaşım". (2010), 208-218.

APA	ŞAHİN S, AKÇİÇEK F (2010). Yaşlı hastada senkopa yaklaşım. Türk Geriatri Dergisi, 13(3), 208 - 218.
Chicago	ŞAHİN SEVNAZ,AKÇİÇEK Fehmi Yaşlı hastada senkopa yaklaşım. Türk Geriatri Dergisi 13, no.3 (2010): 208 - 218.
MLA	ŞAHİN SEVNAZ,AKÇİÇEK Fehmi Yaşlı hastada senkopa yaklaşım. Türk Geriatri Dergisi, vol.13, no.3, 2010, ss.208 - 218.
AMA	ŞAHİN S,AKÇİÇEK F Yaşlı hastada senkopa yaklaşım. Türk Geriatri Dergisi. 2010; 13(3): 208 - 218.
Vancouver	ŞAHİN S,AKÇİÇEK F Yaşlı hastada senkopa yaklaşım. Türk Geriatri Dergisi. 2010; 13(3): 208 - 218.
IEEE	ŞAHİN S,AKÇİÇEK F "Yaşlı hastada senkopa yaklaşım." Türk Geriatri Dergisi, 13, ss.208 - 218, 2010.
ISNAD	ŞAHİN, SEVNAZ - AKÇİÇEK, Fehmi. "Yaşlı hastada senkopa yaklaşım". Türk Geriatri Dergisi 13/3 (2010), 208-218.